Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

ClinicalTrials.gov ID: NCT04115748

Public ClinicalTrials.gov record NCT04115748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 8:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo and Adalimumab-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

Study identification

NCT ID
NCT04115748
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
67 participants

Conditions and interventions

Interventions

  • Adalimumab Drug
  • Filgotinib Drug
  • Placebo to match adalimumab Drug
  • Placebo to match filgotinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2019
Primary completion
Jan 18, 2021
Completion
May 10, 2021
Last update posted
May 15, 2022

2019 – 2021

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Medvin Clinical Research Covina California 91723
Bay Area Arthritis and Osteoporosis Brandon Florida 33511
Omega Research Debary, LLC DeBary Florida 32713
San Marcus Research Clinic, Inc. Miami Florida 33015
Hmd Research Llc Orlando Florida 32819
Arthritis Center, Inc. Palm Harbor Florida 85234
ForCare Clinical Research Tampa Florida 33613
BayCare Medical Group, Inc. Tampa Florida 33614
North Georgia Rheumatology Group Lawrenceville Georgia 30046
Klein & Associates, M.D., P.A. Hagerstown Maryland 21740
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081
St. Paul Rheumatology, P.A. Eagan Minnesota 55121
Arthritis Consultants, Inc. St Louis Missouri 63141
Physician Research Collaaboration, LLCs Lincoln Nebraska 68516
Atlantic Coast Research Toms River New Jersey 08755
Joint and Muscle Research Institute Charlotte North Carolina 28204
Paramount Medical Research & Consulting, LLC Middleburg Heights Ohio 44130
Clinical Research Source Inc Perrysburg Ohio 43551
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Articularis Healthcare Inc, dba, Columbia Arthritis Center, PA Columbia South Carolina 29204
ACME Research, LLC Orangeburg South Carolina 29118
Arthritis & Osteoporosis Clinic of Brazos Valley (Drug Shipment Address) College Station Texas 77845
Southwest Rheumatology Research, LLC Mesquite Texas 75150
West Virginia Research Institute PLLC South Charleston West Virginia 25309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04115748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2022 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04115748 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →